Johnson Carrie L, Nicholas Amy, Divine Holly, Perrier Donald G, Blumenschein Karen, Steinke Douglas T
College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):722-30. doi: 10.1331/JAPhA.2008.07133.
To describe outcomes attained by the DiabetesCARE component of the PharmacistCARE program, which is an innovative pharmacy practice model implemented within a self-insured employer.
Descriptive nonexperimental study.
University of Kentucky (UK), from March 2003 through December 2006.
236 patients with diabetes (95% with type 2 diabetes).
Three clinical pharmacists provided UK Health Plan (UKHP) members with diabetes with comprehensive disease state and medication therapy management.
Clinical outcomes included glycosylated hemoglobin (A1C), fasting lipid panels, blood pressure, weight, vaccination rates, and aspirin use. Humanistic outcomes included the mental and physical components of the 12-Item Short-Form Health Survey (SF-12) and patient satisfaction with health services related to their diabetes care. Screening parameters included the proportion of patients meeting Healthcare Effectiveness Data and Information Set expectations for patients with diabetes. Productivity and health resource use were also assessed based on patient responses to survey questions.
After 1 year of enrollment, patients in the DiabetesCARE program achieved improved clinical outcomes compared with baseline, as evidenced by statistically significant reductions in A1C, low-density lipoprotein cholesterol, triglycerides, and total cholesterol. Statistically significant increases were seen in high-density lipoprotein cholesterol and the proportion of patients obtaining influenza vaccine, yearly screenings for lipid level assessment, screenings for kidney disease, and eye examinations. The mental component score of the SF-12 was significantly increased. Patients were highly satisfied with the DiabetesCARE service, and satisfaction with their overall diabetes care within UKHP was significantly enhanced. Based on the patient provided survey data analyzed here, productivity and health resource use were unchanged; however, additional analyses using UKHP claims data are ongoing.
The DiabetesCARE program is a unique pharmacist-provided service delivered in a freestanding pharmacist clinic that enhances health outcomes for adult members with diabetes in a self-insured employer group.
描述药剂师关爱计划中的糖尿病关爱项目所取得的成果，该计划是在一家自我投保的雇主机构内实施的创新型药学实践模式。
描述性非实验性研究。
肯塔基大学（UK），时间为2003年3月至2006年12月。
236名糖尿病患者（95%为2型糖尿病患者）。
三名临床药剂师为英国健康计划（UKHP）的糖尿病患者提供全面的疾病状态和药物治疗管理。
临床结局包括糖化血红蛋白（A1C）、空腹血脂指标、血压、体重、疫苗接种率和阿司匹林使用情况。人文结局包括12项简短健康调查问卷（SF - 12）的心理和生理分量表，以及患者对与糖尿病护理相关的健康服务的满意度。筛查参数包括达到糖尿病患者医疗保健有效性数据和信息集预期的患者比例。还根据患者对调查问题的回答评估了生产力和健康资源利用情况。
入组1年后，糖尿病关爱项目的患者与基线相比临床结局有所改善，A1C、低密度脂蛋白胆固醇、甘油三酯和总胆固醇有统计学意义的显著降低证明了这一点。高密度脂蛋白胆固醇以及获得流感疫苗、每年进行血脂水平评估筛查、肾病筛查和眼部检查的患者比例有统计学意义的显著增加。SF - 12的心理分量表得分显著提高。患者对糖尿病关爱服务高度满意，并且对他们在UKHP内的整体糖尿病护理的满意度显著增强。根据此处分析的患者提供的调查数据，生产力和健康资源利用情况未变；然而，使用UKHP理赔数据的其他分析正在进行中。
糖尿病关爱项目是一项由药剂师在独立的药剂师诊所提供的独特服务，可改善自我投保雇主群体中成年糖尿病患者的健康结局。
